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Background: Obstructive sleep apnea (OSA) is a high prevalence sleep disorder characterized by upper airway
obstruction during sleep, nocturnal intermittent hypoxemia, poor sleep quality, risk for cardiovascular and metabolic
diseases. The adherence to CPAP is the key for an effective management of these patients.
The aim of the study was to assess the adherence to CPAP therapy with and without early reinforcing interventions,
consisting of motivational reinforcement and technical support in the first month of therapy.
Methods: Forty patients with OSA undergoing counseling and a one year follow-up on a quarterly basis were
included in the study. Twenty subjects (intervention group) underwent reinforcing interventions with telephone
interviews in the first month of therapy, and twenty (control group) remained without reinforcing interventions.
The two populations were homogeneous for age, severity of illness and BMI.
Results: During the first month, intervention group patients showed a higher number of nights with a device
use ≥4 hours. Average treatment adherence in the first month (days of therapy with at least 4 hours per night
on the total number of days from device delivery) was 77.5% in the intervention group and 55.7% in the control
group (p = 0.022). At one year the differences between the two groups were not significant.
Conclusions: Our findings suggest that it is important that adequate time and effort is spent to ensure patient
comfort at the time of CPAP therapy start to optimize acceptance and adherence to treatment, and suggest that
it is necessary to maintain reinforcing interventions over time.
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Obstructive sleep apnea (OSA) is a common sleep disorder
characterized by intermittent partial or complete upper
airway obstruction during sleep, associated to recurrent
arousals, nocturnal intermittent hypoxemia, sleep frag-
mentation and poor sleep quality. The prevalence of
OSA associated with accompanying excessive daytime
sleepiness (EDS) is approximately 3 to 7% in adult men
and 2 to 5% in adult women in the general population
[1]. Factors that increase vulnerability to the disorder
include age, male sex, obesity, craniofacial abnormal-
ities, family history, menopause, and behaviours such as
cigarette smoking and alcohol use [1].
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unrefreshed at wake-up, EDS or fatigue, lack of concentra-
tion, memory impairment, and at times neurobehavioural
disturbances [2]. OSA is an independent risk factor for
cardiovascular diseases, including hypertension, atrial
fibrillation, coronary artery disease, stroke [3], and for
metabolic diseases like type 2 diabetes [4]. OSA is associ-
ated with automobile accidents [5], reduced participation
in work activities, increased absenteeism, and a loss of
productivity, with a consequent increase in the use of
resources [6]. Severe OSA is associated with increased
mortality, especially in young subjects. Although mor-
tality risk associated with OSA tends to disappear from
the age of 50, it has been suggested that OSA treatment
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ence to CPAP treatment is important, since when CPAP
is adequately used it eliminates apneas, improves sleep
quality and health related quality of life (HRQoL), and
reduces EDS [8]. Furthermore, it can reduce morbidity
and mortality from cardiovascular diseases as well as
consumption of health care resources. However it is not
always well tolerated. It requires follow-up, and the
adherence rates are often low [8]. Adherence to CPAP
therapy is the key for effective management of OSA
patients. Epidemiological data show that on average 25%
of OSA patients do not accept CPAP treatment and, of
those who undertake the therapy, only 30-60% can be
considered adherent [8]. An acceptable adherence to
therapy is usually considered a minimum of 4 hours/
night for at least 70% of the nights of therapy [9]. Some
of the key determinants of CPAP rejection and non-
adherence may include apprehension regarding how CPAP
will make patients look and feel, interference with normal
life and sexual functioning, and other behavioural or
psychological factors [10]. In order to enhance adherence
to CPAP, treatment should be presented as desirable
for the patient, must not appear too complex, must be
proposed several times, and must be effective.
Several recent studies [11-13] show that adherence to
CPAP therapy can be improved with some strategies:
patient educational training and information at the start
of therapy, timely approach to the resolution of possible
causes of non-adherence to therapy, structured follow-
up and motivational support. However, the effects in
the long-term of a short early motivational support on
adherence to treatment are poorly known.
The aim of the study was to assess the adherence to
CPAP therapy with and without early reinforcing inter-
ventions, consisting of motivational reinforcement and
technical support in the first month of therapy, and to
evaluate if the possible benefit of the support could extend
to one year.
Methods
Forty consecutive patients (27 male and 13 female) older
than 18 years, with diagnosis of OSA and indication to
CPAP treatment, according to international guidelines
[14,15], were recruited by the sleep disordered breathing
Centre of IBIM-CNR Palermo. The total number of 40
patients was chosen a priori. The protocol was approved
by the local ethical committee (Azienda Ospedaliera
Universitaria Policlinico Paolo Giaccone dell’Università
degli Studi di Palermo) and all persons gave their written
informed consent prior to their inclusion in the study.
Patients with impairments or comorbidities considered
likely to interfere with adherence to instructions were
excluded: neuromuscular disease, unstable psychiatric
disease or cognitive impairment considered likely tointerfere with adherence to instructions, myocardial infarc-
tion, unstable angina, cardiac failure, cerebrovascular acci-
dent, lung disease with awake resting oxygen saturation of
less than 90%.
Nocturnal cardiorespiratory recording (Somté or Somnea
Compumedics, Abbotsford, Australia) was performed for
diagnosis of OSA. On the cardiorespiratory recordings,
time between estimated first sleep onset and last morning
awakening was analyzed. Apneas and hypopneas were
manually analyzed. Apneas were identified on the airflow
signal, and were classified as obstructive, central, or mixed,
according to behaviour of thoraco-abdominal movements.
Hypopneas were scored when a ≥30% reduction in the
airflow signal was detected in association with a reduc-
tion ≥4% of oxyhemoglobin saturation (SaO2) [15]. Apnea/
hypopnea index (AHI) was calculated as the number of
(apneas + hypopneas)/h of recording that was analyzed.
Time with SaO2 below 90% (TSat ≤90%) was calculated.
Before CPAP titration, all patients were informed by the
medical personnel about the diagnosis with a description
of the disease and the consequences of ineffective treat-
ment, and about the follow-up. Then, the nursing staff
identified the suitable mask and held a morning session of
education and training to the CPAP therapy. The duration
of this phase was about 30 minutes. In lab CPAP titration
was performed with the AutoSet (ResMed Abingdon UK)
auto-titrating CPAP device with full nocturnal polysom-
nography. Throughout the night and the next morning,
the nurses on duty dealt with any discomfort related to
the CPAP treatment. Fixed CPAP was prescribed to each
patient at the pressure needed to abolish obstructive
respiratory events, airflow limitation and snoring, as
determined by the overnight AutoSet CPAP titration
study. The same CPAP machine was given to every
patient (Weinmann SOMNOcomfort 2e) and all subjects
were advised to use their CPAP machine as often as
possible when asleep. Then patients were randomised
to receive extra early support (intervention group) or
standard follow-up (control group).
After receiving the CPAP device, all patients were pro-
vided with a telephone number to call the doctor of the
sleep centre for support within office hours. The home
care provider visited all patients at their home at month
3, 6, 12 from the start of therapy, and each time he
downloaded data from the device memory (time of device
use per night), controlled BMI, administered Epworth
Sleepiness Scale (ESS), and transmitted all data to the
sleep centre that analyzed them. In the intervention
group ESS was administered also the 30th day from the
beginning of the therapy.
Patients in the intervention group received a standard-
ized daily telephone interview from their sleep doctor on
the first week of therapy and at one month after therapy
start. During the interview they were asked about the
Table 1 Subjects baseline characteristics
Study Intervention group (n. 20) Control group (n. 20) p
AGE (yr) 58.55 ± 13.2 55.65 ± 8.25 ns
AHI (n/h) 44.05 ± 16.90 44.45 ± 25.18 ns
BMI (kg/m2) 33.93 ± 5.44 34 ± 5.99 ns
ESS 8.95 ± 5.74 10.55 ± 6.21 ns
TSat ≤90% 20.88 ± 15.22 20.77 ± 22.03 ns
AHI (apnea-hypopnea index), BMI (body mass index), ESS (Epworth Sleepiness
Score); TSat ≤90% (% of study time with oxygen saturation below 90%).
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abrasions or rashes, nasal pain, conjunctivitis from air
leakage, bloating, sinusitis and rhinitis, difficulty in breath-
ing out, sense of chest tightness, dryness of the nose and
mouth, nosebleeds. The doctor reviewed progress and
gave advice to manage CPAP-related adverse effects, and
encouraged to maintain adherence to therapy. Besides,
when necessary, technical support was given by the home
care provider. The protocol is shown in Figure 1.
Statistical analysis
The effect of the support on CPAP adherence, defined
as the monthly average number of days of therapy ≥4
hours, was evaluated by non parametric Wilcoxon/Kruskal-
Wallis test. Data were reported as mean ± SD. A p <0.05
was considered significant. Statistical analysis was performed
by commercial software (JMP 8.0 SAS Institute Inc.).
Results
The anthropometric and clinical data of the study sample
are shown in Table 1. The two groups were homogeneous
for age, severity of illness, TSat ≤90%, BMI, daytimeCPAP TITRATION







1st week and 30th day
Download compliance data
and control of BMI and ESS: 
3rd, 6th and 12th month
40 OSAS Patients 
Figure 1 Flow-diagram showing the path of the proposed
support. OSAS, obstructive sleep apnea syndrome; CPAP, continuous
positive airway pressure; BMI, body mass index; ESS, Epworth Sleepiness
Score.sleepiness assessed by ESS. Reinforcing intervention
patients used CPAP no longer compared to control
group (mean 4.3 hr/night vs 3.8 hr/night and median
5.1 hr/night vs 4.5 hr/night) in one year.
In the intervention group, one subject was not available
at the 12th month of follow-up. In the control group,
one subject was not traceable from the 3rd month, and
another one at 12th month of follow-up.
Complaints of the patients during the first month were
addressed in real time with immediate action. The most
frequent complaints regarded nose and mouth dryness:
this problem was fixed with replacement of the CPAP
humidifier in two cases, and with replacement of nasal
with full face mask in 3 subjects. In two cases topical
products for abrasions due to the mask were prescribed.
The level of the therapeutic pressure was reduced of 1
cm H2O in 2 patients for reported sense of excessive
pressure. During the first month of treatment with
support, one patient was not adherent to therapy for
nocturnal xerostomia that did not improve either with
an increase of the heat humidifier or after replacement
of the nasal mask with a face mask. Patients of the
intervention group showed a higher number of nights
with a device use ≥4 hours (23.2 days in the intervention
group vs 16.0 for the control group, p = 0.022). Average
treatment adherence was 77.5% in the intervention group
and 55.7% in the control group.
The difference in adherence became non-significant at
the 2nd, 3rd month and at the 2nd, 3rd and 4th quarter
(Figure 2). At second quarter compliance was 66.7% in
the intervention group vs 58.3% in the control group
(p = NS), and at fourth quarter adherence was 54.3% in
the intervention group vs 56.3% in the control group
(p = NS). Both in the intervention and in the control
group, daytime sleepiness measured by the ESS was
lower at the 3rd, 6th and 12th month than at baseline with
no significant differences between the two groups (Table 2).
The reduction of adherence through time covered all the
patients equally, irrespective of initial ESS.
Discussion
Although many patients with OSA benefit from treatment


























1°month 2°month 3°month 2°quarter 3°quarter 4°quarter
Figure 2 Average treatment adherence during the follow-up:
mean (±SE) monthly number of nights with use >4 hours for
intervention group and control group. The asterisk indicates a
statistically significant difference between two means.
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multifactorial: from medical and physiological factors,
to equipment-related side effects and technical factors. A
wide variety of approaches might improve CPAP adherence
in the real world: education to CPAP, additional support,
telemedicine approaches, use of hypnotic sleep aids,
cognitive behavioural treatments [16]; among possible
interventions to enhance CPAP use, we used telephone
support, increased interaction with sleep provider, planned
follow-up. The aim of the study was to assess the effect of
a short time reinforcing intervention on the adherence
to CPAP therapy in the months following interruption
of the support. The assistance consisted of motivational
reinforcement, technical and clinical support on the first
month of therapy. The activated support led to better
adherence to therapy in terms of number of nights with
use ≥4 hours during the first month. However the ben-
efits of the support during the first month diminished
later and did not extend to one year.
Like other studies [17,18], we used a type of interven-
tion and support only in the initial phase of therapy with
standardized telephone calls during the first week and
on the 30th day from delivery of the device. During the
phone contact, medical staff supported the patient process
of acceptance of the chronic therapy, with the assistance
of the home care provider at home. Some studies have
shown that early low adherence to therapy is a feature of
patients quitting treatment in the first year of use. Mc
Ardle et al. [19] studied 1,103 patients with a median
follow-up of 22 months and found that compliance at 3
months was strongly predictive of long-term use.Table 2 Epworth sleepiness score during follow-up
Study ESS baseline ESS 1°month
EES intervention group 8.95 ± 5.74 3.6. ± 2.43
EES control group 10.55 ± 6.21
Daytime sleepiness measured by the ESS (Epworth Sleepiness Score), baseline, at thBroström et al. [10] analyzed the facilitators and barriers
to CPAP adherence in a sample of 23 patients and
concluded that emotional and practical shortfalls support
over the first days of therapy do not improve adherence. A
more prolonged intervention may be necessary to keep
for as long as possible the effect of the additional support.
Hoy et al. [20] clearly showed for the first time that an
intensive support ended in an improvement of the thera-
peutic observance of the CPAP over 6 months, with greater
improvement in OSA symptoms, mood, and reaction time.
In this study, unlike in our studies, the bed partners were
actively involved in the initial phase of education to CPAP,
three nights CPAP titration in the sleep center were
performed, a home visit at the 14th day and at the begin-
ning of the fourth month therapy was made. Probably,
these factors were important reinforcing elements in the
long-term adherence to CPAP therapy [20].
Lewis et al. [17] recruited in a sleep centre seventy-two
consecutive patients starting CPAP for OSA who were
randomised to receive standard follow-up or extra early
support. Patients had further appointments with a sleep
physician at sleep centre at 1 month, 6 months and 12
months. However, almost a third of patients in the control
group failed to attend at 6 months, so that reliable data on
CPAP use, ESS and side-effects were lacking. In contrast
to this and other studies, our protocol actively involved an
home care provider in the immediate management and
resolution of patients’ problems. This allowed us to accur-
ately obtain the adherence data, unlike in other studies
[17] where an active participation of the patient for data
collection was expected.
Another randomized, controlled, parallel study about
effects of basic vs augmented CPAP education and support,
based on a sample of 108 patients of the Chinese popula-
tion, assessed outcomes of extra early CPAP education and
support. The authors analyzed quality of life by Calgary
sleep apnea quality of life index, and cognitive function
after 1 month and 3 months: unlike in our study, augmen-
tation of CPAP education and support did not increase
CPAP compliance, but led to a greater improvement in
quality of life during the reinforced period [18].
Attitudes and beliefs as well as early problems and poor
initial CPAP usage are strongly predictive of long-term
poor adherence [21-24]. Consequently, early interventions
targeting issues surrounding CPAP knowledge, benefits
and expectations, the initial novel experience, and com-
mon problems in achieving sleep with CPAP may beESS 3°month ESS 6°month ESS 12°month
4.35 ± 3.34 5.05 ± 4.31 5.68 ± 4.02
5.10 ± 3.32 4.16 ± 2.14 4.00 ± 2.82
e 3rd, 6th and 12th month.
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management [9]. Adequate early support is of major
importance for addressing psychosocial and behavioural
barriers establishing effective CPAP treatment; the early
management of technical problems is clearly important
to improve compliance [13,25].
Aloia et al. [26] applied time series analysis to examine
the differences in individual adherence to CPAP therapy
on a sample of 70 OSA subjects and identified 7 different
categories of adherence: good users, slow improvers,
slow decliners, variable users, occasional attempters, early
drop-outs and non-users. Although CPAP adherence is
generally established early, two subjects of their groups
(slow improvers and slow decliners) developed new, yet
consistent, use patterns later into therapy. Their results
suggest that two reinforcing intervention times may be
relevant when targeting CPAP adherence: in the early
course of treatment and at 3 to 6 months of treatment.
Aloia’s study results, and the inefficacy of our early sup-
port alone, show that the focus on adherence should not
be withdrawn after the first month.
Strengths of our study are its randomised, controlled
design, and the active participation of the home care
provider with the sleep center. A weakness is a single
center study with a relatively modest number of patients
and the lack of additional support over the first month.
Nevertheless, it allowed us to demonstrate a significant
effect of the support program. Repeating these results in
other studies would be relevant to confirm the benefit.
Conclusions
Our findings suggest that it is important that adequate
time and effort is spent to ensure patient comfort when
CPAP therapy is initiated to optimize acceptance and
adherence to treatment, and suggest that it is necessary to
maintain reinforcing interventions over time. Although
we can measure side effects and improve re-attendance,
more work is necessary to tailor interventions for early
identification of poor users, and especially to look out for
patients who do not re-attend at all.
Our experience has confirmed the benefit of a medical,
motivational and technical support in the first month.
However it was not effective in the long term, suggesting
that patients treated with CPAP need to maintain a
reinforcement beyond the first month of therapy.
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